Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lawrence X Yu

Showing results (41-50 of 75) with videos related to

Pageof 8
Sort By:
Molecular Pharmaceutics|August 13, 2010
High-permeability criterion for BCS classification: segmental/pH dependent permeability considerationsArik Dahan, Jonathan M Miller, John M Hilfinger, et al.
The AAPS Journal|April 5, 2015
A Bioequivalence Approach for Generic Narrow Therapeutic Index Drugs: Evaluation of the Reference-Scaled Approach and Variability Comparison CriterionWenlei Jiang, Fairouz Makhlouf, Donald J Schuirmann, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|June 16, 2004
Biowaiver extension potential to BCS Class III high solubility-low permeability drugs: bridging evidence for metformin immediate-release tabletChing-Ling Cheng, Lawrence X Yu, Hwei-Ling Lee, et al.
The AAPS Journal|June 5, 2009
In vitro considerations to support bioequivalence of locally acting drugs in dry powder inhalers for lung diseasesSau Lawrence Lee, Wallace P Adams, Bing V Li, et al.
The AAPS Journal|May 24, 2014
Understanding pharmaceutical quality by designLawrence X Yu, Gregory Amidon, Mansoor A Khan, et al.
The AAPS Journal|May 16, 2015
Erratum to: A Bioequivalence Approach for Generic Narrow Therapeutic Index Drugs: Evaluation of the Reference-Scaled Approach and Variability Comparison CriterionWenlei Jiang, Fairouz Makhlouf, Donald J Schuirmann, et al.
Advanced Drug Delivery Reviews|February 14, 2004
Regulatory considerations of pharmaceutical solid polymorphism in Abbreviated New Drug Applications (ANDAs)Andre S Raw, M Scott Furness, Devinder S Gill, et al.
International Journal of Pharmaceutics|August 2, 2011
The role of predictive biopharmaceutical modeling and simulation in drug development and regulatory evaluationWenlei Jiang, Stephanie Kim, Xinyuan Zhang, et al.
AAPS Pharmscitech|August 15, 2003
Near-infrared spectral imaging for quality assurance of pharmaceutical products: analysis of tablets to assess powder blend homogeneityRobbe C Lyon, David S Lester, E Neil Lewis, et al.
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|May 15, 2012
Preclinical pharmacokinetics of MI-219, a novel human double minute 2 (HDM2) inhibitor and prediction of human pharmacokineticsPeng Zou, Nan Zheng, Yanke Yu, et al.
Pageof 8

Showing results (41-50 of 75) with videos related to

Sort By:
Pageof 8
Molecular Pharmaceutics|August 13, 2010
High-permeability criterion for BCS classification: segmental/pH dependent permeability considerationsArik Dahan, Jonathan M Miller, John M Hilfinger, et al.
The AAPS Journal|April 5, 2015
A Bioequivalence Approach for Generic Narrow Therapeutic Index Drugs: Evaluation of the Reference-Scaled Approach and Variability Comparison CriterionWenlei Jiang, Fairouz Makhlouf, Donald J Schuirmann, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|June 16, 2004
Biowaiver extension potential to BCS Class III high solubility-low permeability drugs: bridging evidence for metformin immediate-release tabletChing-Ling Cheng, Lawrence X Yu, Hwei-Ling Lee, et al.
The AAPS Journal|June 5, 2009
In vitro considerations to support bioequivalence of locally acting drugs in dry powder inhalers for lung diseasesSau Lawrence Lee, Wallace P Adams, Bing V Li, et al.
The AAPS Journal|May 24, 2014
Understanding pharmaceutical quality by designLawrence X Yu, Gregory Amidon, Mansoor A Khan, et al.
The AAPS Journal|May 16, 2015
Erratum to: A Bioequivalence Approach for Generic Narrow Therapeutic Index Drugs: Evaluation of the Reference-Scaled Approach and Variability Comparison CriterionWenlei Jiang, Fairouz Makhlouf, Donald J Schuirmann, et al.
Advanced Drug Delivery Reviews|February 14, 2004
Regulatory considerations of pharmaceutical solid polymorphism in Abbreviated New Drug Applications (ANDAs)Andre S Raw, M Scott Furness, Devinder S Gill, et al.
International Journal of Pharmaceutics|August 2, 2011
The role of predictive biopharmaceutical modeling and simulation in drug development and regulatory evaluationWenlei Jiang, Stephanie Kim, Xinyuan Zhang, et al.
AAPS Pharmscitech|August 15, 2003
Near-infrared spectral imaging for quality assurance of pharmaceutical products: analysis of tablets to assess powder blend homogeneityRobbe C Lyon, David S Lester, E Neil Lewis, et al.
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|May 15, 2012
Preclinical pharmacokinetics of MI-219, a novel human double minute 2 (HDM2) inhibitor and prediction of human pharmacokineticsPeng Zou, Nan Zheng, Yanke Yu, et al.
Pageof 8